1Lee TC, Savoldo B, Rooney CM, et al. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant, 2005, 5:2222-2228.
2Swinnen LJ, LeBlanc M, Grogan TM, et al. Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. Transplantation, 2008, 86:215-222.
3Brunstein CG, Weisdorf DJ, DeFor T, et al. Marked increased risk of Epstcin-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood, 2006,108 : 2874-2880.
4Powell JL, Bunin NJ, Callahan C, et al. An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34 + selected autologous peripheral blood stem cell transplant in neuroblastorna. Bone Marrow Transplant, 2004, 33:651-657.
5Wang Q, Liu H, Zhang X, et al. High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood. Blood, 2010, 116: 5941-5947.
6Wilkie GM, Taylor C, Jones MM, et al. Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases. J Immunother, 2004, 27:309-316.
7Haque T, Wilkie GM, Taylor C, et al. Treatment of Epstein-Barr- virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet, 2002, 360:436-442.
8Bollard CM, Aguilar L, Straathof KC, et al. Cytotoxic T lymphocyte therapy for Epstein-Barr virus + Hodgkin's disease. J Exp Med, 2004,200 : 1623-1633.
9Cho HI, Hong YS, Lee MA, et al. Adoptive transter of Epstein- Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas. Int J Hematol, 2006,83:66-73.
10Lucas KG, Salzman D, Gareia A, et al. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T- lymphocytes for recurrent, EBV-positive Hodgkin disease. Cancer, 2004, 100 : 1892-1901.
